Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cibula

Showing results (61-70 of 154) with videos related to

Pageof 16
Sort By:
Ceska Gynekologie|August 16, 2011
[Hereditary susceptibility to endometrial cancer]M Zikán, J Sláma, I Pinkavová, et al.
Ceska Gynekologie|November 24, 1999
[Clinical study of a triphasic contraceptive preparation (Norgestimate 180/215/250 micrograms + ethinylestradiol 35 micrograms) in a population of Czech women]J Paseka, V Unzeitig, J Horejsí, et al.
Human Reproduction (Oxford, England)|July 2, 2003
Pregnancy outcome in women with PCOS and in controls matched by age and weightL Haakova, D Cibula, K Rezabek, et al.
Folia Biologica|May 24, 2008
Chromosomal rearrangements and their relations to histopathological and clinical parameters in epithelial ovarian cancerN Jancarková, M Krkavcová, M Janashia, et al.
Ceska Gynekologie|December 5, 2014
Tailoring surgical treatment of cervical precancerosisB Sehnal, D Driák, D Cibula, et al.
Vnitrni Lekarstvi|September 25, 2003
[Consensus statement regarding indications for Leiden (FVL-factor V Leiden) mutation determination when recommending combined hormonal contraception or hormone replacement therapy]D Cibula, J Kvasnicka, P Salaj, et al.
Ceska Gynekologie|August 23, 2000
[Prediction of the effect of a triphasic contraceptive agent with norgestimate on acne]D Cibula, J Paseka, V Unzeitig, et al.
Ceska Gynekologie|August 23, 2000
[The factor V Leiden mutation in users of hormonal contraceptives]J Paseka, V Unzeitig, D Cibula, et al.
Ceska Gynekologie|October 20, 2000
[Initial experience with the Versapoint bipolar electrode in hysteroscopic tissue vaporization]D Tóth, D Kuzel, Z Fucíková, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 11, 2014
Bone quality assessment in type 2 diabetes mellitusR Dhaliwal, D Cibula, C Ghosh, et al.
Pageof 16

Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
Ceska Gynekologie|August 16, 2011
[Hereditary susceptibility to endometrial cancer]M Zikán, J Sláma, I Pinkavová, et al.
Ceska Gynekologie|November 24, 1999
[Clinical study of a triphasic contraceptive preparation (Norgestimate 180/215/250 micrograms + ethinylestradiol 35 micrograms) in a population of Czech women]J Paseka, V Unzeitig, J Horejsí, et al.
Human Reproduction (Oxford, England)|July 2, 2003
Pregnancy outcome in women with PCOS and in controls matched by age and weightL Haakova, D Cibula, K Rezabek, et al.
Folia Biologica|May 24, 2008
Chromosomal rearrangements and their relations to histopathological and clinical parameters in epithelial ovarian cancerN Jancarková, M Krkavcová, M Janashia, et al.
Ceska Gynekologie|December 5, 2014
Tailoring surgical treatment of cervical precancerosisB Sehnal, D Driák, D Cibula, et al.
Vnitrni Lekarstvi|September 25, 2003
[Consensus statement regarding indications for Leiden (FVL-factor V Leiden) mutation determination when recommending combined hormonal contraception or hormone replacement therapy]D Cibula, J Kvasnicka, P Salaj, et al.
Ceska Gynekologie|August 23, 2000
[Prediction of the effect of a triphasic contraceptive agent with norgestimate on acne]D Cibula, J Paseka, V Unzeitig, et al.
Ceska Gynekologie|August 23, 2000
[The factor V Leiden mutation in users of hormonal contraceptives]J Paseka, V Unzeitig, D Cibula, et al.
Ceska Gynekologie|October 20, 2000
[Initial experience with the Versapoint bipolar electrode in hysteroscopic tissue vaporization]D Tóth, D Kuzel, Z Fucíková, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 11, 2014
Bone quality assessment in type 2 diabetes mellitusR Dhaliwal, D Cibula, C Ghosh, et al.
Pageof 16